It was previously confirmed that CCL2 (MCP1) was upregulated in serum, CSF, and peripheral blood mononuclear cell in ALS patients (Kuhle et al., 2009; Gupta et al., 2011a,b). Here, CCL2 is linked to amyotrophic lateral sclerosis.